(Q35909546)

11 August 2017

The 70-Gene Signature as Prognostic Factor for Elderly Women with Hormone Receptor-Positive, HER2-Negative Breast Cancer (English)

1 reference

11 August 2017

Steffi Hartmann

1

1 reference

11 August 2017

Bernd Gerber

2

1 reference

11 August 2017

Dirk Elling

3

1 reference

11 August 2017

Kristin Heintze

4

1 reference

11 August 2017

Toralf Reimer

5

1 reference

11 August 2017

13 February 2012

1 reference

11 August 2017

1 reference

11 August 2017

7

1 reference

11 August 2017

1

1 reference

11 August 2017

19-24

1 reference

Quality-of-life considerations in the treatment of early-stage breast cancer in the elderly

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335350

Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335350

Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335350

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335350

Adjuvant therapy in the elderly: making the right decision

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335350

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335350

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335350

Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335350

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335350

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335350

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335350

Gene expression profiling predicts clinical outcome of breast cancer

27 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1159%2F000336552

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1159%2F000336552

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1159%2F000336552

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

21 January 2018

1 reference

12 December 2020

[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]

1 reference

12 December 2020

Tumor characteristics and clinical outcome of elderly women with breast cancer

1 reference

12 December 2020

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

12 December 2020

Identifiers

DOI

10.1159/000336552

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22553468

1 reference